(Q74098915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

H Handa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

U P Hegde

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

V M Kotelnikov

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S D Mundle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L M Dong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P Burke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Rose

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

W T Hsu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

F Gaskin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Raza

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H D Preisler

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

11-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

1087-1096

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

Mobilization of cytogenetically 'normal' blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

Retinoids and interferon: a new promising combination?

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

Protooncogene expression in subpopulations of cells from leukemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

c-myc and c-myb expression in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

Active Cancer Therapy Combining 13-cis-Retinoic Acid With Interferon-

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

Retinoic acid and interferon combination studies in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900090-8

7 January 2021

10.1016/S0145-2126(97)00090-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9444943%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference